Product Images Pioglitazone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Pioglitazone NDC 57237-219 by Rising Health, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1. Mean Change from Baseline for HbA1c in a 26-Week Placebo-Controlled Dose-Ranging Study (Observed Values) - pioglitazone fig1

Figure 1. Mean Change from Baseline for HbA1c in a 26-Week Placebo-Controlled Dose-Ranging Study (Observed Values) - pioglitazone fig1

The text describes the mean change in HbAlc levels in a 26-week, placebo-controlled dose-ranging study. The data is presented graphically in Figure 1, which shows the observed values for three different doses (15mg, 30mg, and 45mg) plotted over time. The x-axis represents the number of weeks in the study, while the y-axis represents the mean change in HbAlc levels from baseline.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg (30 Tablet Bottle) - pioglitazone fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 15 mg (30 Tablet Bottle) - pioglitazone fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 30 mg (30 Tablet Bottle) - pioglitazone fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 30 mg (30 Tablet Bottle) - pioglitazone fig3

Rising® NDC57237-220-3 is a tablet that contains Piogltazon hydrochloride, equivalent to piogitazone 30 mg. The tablet is distributed by Rising Health and manufactured in India. The recommended storage temperature is between 20°C to 25°C, and it should be protected from moisture and humidity. Pharmacists are advised to dispense the accompanying medication guide to each patient and keep it out of the reach of children. If the seal over the bottle opening is broken, do not accept the medication. No information is available on the purpose of this medication or the conditions it is used to treat.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 mg (30 Tablet Bottle) - pioglitazone fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 mg (30 Tablet Bottle) - pioglitazone fig4

The text is a medication label for Pioglitazone tablets, USP. It provides information on the dosage, administration, storage, and distribution of the medication. The pharmacist is advised to dispense the accompanying medication guide to each patient. The medication is distributed by Rising Health, LLC, Saddle Brook, NJ. It also includes a code and a revision date.*

chemical structure - pioglitazone str

chemical structure - pioglitazone str

Not available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.